ES8400871A1 - Una composicion de nitrofurantoina. - Google Patents

Una composicion de nitrofurantoina.

Info

Publication number
ES8400871A1
ES8400871A1 ES516815A ES516815A ES8400871A1 ES 8400871 A1 ES8400871 A1 ES 8400871A1 ES 516815 A ES516815 A ES 516815A ES 516815 A ES516815 A ES 516815A ES 8400871 A1 ES8400871 A1 ES 8400871A1
Authority
ES
Spain
Prior art keywords
dosage form
nitrofurantoin
nitrofurantoin dosage
salt
acrylic resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES516815A
Other languages
English (en)
Other versions
ES516815A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Eaton Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharmaceuticals Inc filed Critical Norwich Eaton Pharmaceuticals Inc
Publication of ES8400871A1 publication Critical patent/ES8400871A1/es
Publication of ES516815A0 publication Critical patent/ES516815A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PREPARACION DE UNA COMPOSICION DE NITROFURANTOINA QUE PERMITE REDUCIR EL NUMERO DE DOSIS EN EL TRATAMIENTO DE LAS INFECCIONES DEL TRACTO URINARIO.SE COMBINA ADECUADAMENTE UNA SAL DE NITROFURANTOINA O UN HIDRATO DE LA MISMA CON EXCIPIENTES ADECUADOS; SE TAMIZA LA MEZCLA ASI OBTENIDA Y SE COMPRIME EN TABLETAS CON UN NUCLEO CONVEXO MEDIANTE COMPRESION DIRECTA UTILIZANDO UNA PRENSA ADECUADA; FINALMENTE SE PULVERIZA SOBRE LAS TABLETAS UNA SUSPENSION DE RESINA ACRILICA A MEDIDA QUE LAS TABLETAS GIRAN EN LA BANDEJA DE RECUBRIMIENTO. ESTA RESINA ES DE LA CLASE FORMADA PORPOLIMERO ANIONICO SINTETIZADO A PARTIR DE ACIDO METACRILICO Y ESTER METILICO DEL ACIDO METACRILICO.
ES516815A 1981-10-26 1982-10-25 Una composicion de nitrofurantoina. Granted ES516815A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/314,656 US4370313A (en) 1981-10-26 1981-10-26 Nitrofurantoin dosage form

Publications (2)

Publication Number Publication Date
ES8400871A1 true ES8400871A1 (es) 1983-12-01
ES516815A0 ES516815A0 (es) 1983-12-01

Family

ID=23220880

Family Applications (1)

Application Number Title Priority Date Filing Date
ES516815A Granted ES516815A0 (es) 1981-10-26 1982-10-25 Una composicion de nitrofurantoina.

Country Status (18)

Country Link
US (1) US4370313A (es)
EP (1) EP0078079B1 (es)
JP (1) JPS5883618A (es)
AT (1) AT387142B (es)
AU (1) AU557553B2 (es)
CA (1) CA1181695A (es)
DE (1) DE3276522D1 (es)
DK (1) DK472182A (es)
ES (1) ES516815A0 (es)
FI (1) FI823624L (es)
GR (1) GR77686B (es)
IE (1) IE54083B1 (es)
IL (1) IL66961A (es)
NO (1) NO157805C (es)
NZ (1) NZ202140A (es)
PH (1) PH17286A (es)
PT (1) PT75731B (es)
ZA (1) ZA827457B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US5560909A (en) * 1986-06-03 1996-10-01 Dowelanco Insecticidal compositions and process for preparation thereof
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4822629A (en) * 1986-12-12 1989-04-18 Norwich Eaton Pharmaceuticals, Inc. Azumolene dosage form
US4938966A (en) * 1988-11-30 1990-07-03 Riker Laboratories, Inc. Controlled release flecainide acetate formulation
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
DE19959419A1 (de) * 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
MXPA05002136A (es) * 2002-08-23 2005-06-03 Ranbaxy Lab Ltd Forma de dosificacion de liberacion controlada de nitrofurantoina.
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
EP2496337A1 (en) * 2009-11-08 2012-09-12 Jean Patrick Montoya Method for forming hollow fibers and bundles thereof
CN108553443B (zh) * 2018-04-24 2020-09-01 江苏四环生物制药有限公司 一种呋喃妥因肠溶片的制备方法
IT201900000897A1 (it) * 2019-01-22 2020-07-22 Phf S A Formulazione a rilascio prolungato a permanenza gastrica a base di nitrofurantoina
CN116172969A (zh) * 2023-02-13 2023-05-30 山西太原药业有限公司 一种肠溶包衣、呋喃妥因肠溶制剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE644759C (de) * 1932-11-23 1937-05-12 I G Farbenindustrie Akt Ges Verfahren zum UEberziehen von Arzneiformen mit gegen Magensaeure und Magenfermente bestaendigen UEberzuegen
NL248552A (es) * 1959-02-18
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
DE1931910B2 (de) * 1969-06-24 1974-11-28 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3641237A (en) * 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication

Also Published As

Publication number Publication date
PT75731A (en) 1982-11-01
IL66961A (en) 1986-02-28
FI823624A0 (fi) 1982-10-25
NO157805B (no) 1988-02-15
US4370313A (en) 1983-01-25
EP0078079A2 (en) 1983-05-04
AU8965182A (en) 1983-05-05
DE3276522D1 (en) 1987-07-16
EP0078079A3 (en) 1983-06-29
IE822454L (en) 1983-04-26
NO823534L (no) 1983-04-27
AT387142B (de) 1988-12-12
PH17286A (en) 1984-07-06
GR77686B (es) 1984-09-25
AU557553B2 (en) 1986-12-24
PT75731B (en) 1985-06-28
ES516815A0 (es) 1983-12-01
NZ202140A (en) 1985-12-13
DK472182A (da) 1983-04-27
CA1181695A (en) 1985-01-29
JPS5883618A (ja) 1983-05-19
ZA827457B (en) 1984-05-30
ATA390382A (de) 1988-05-15
NO157805C (no) 1988-05-25
IE54083B1 (en) 1989-06-07
FI823624L (fi) 1983-04-27
IL66961A0 (en) 1983-02-23
EP0078079B1 (en) 1987-06-10
JPS6241646B2 (es) 1987-09-03

Similar Documents

Publication Publication Date Title
ES8400871A1 (es) Una composicion de nitrofurantoina.
EG15774A (en) Method of preparation of insecticidal and acaricidal combination based on a pyethroid
DE3067956D1 (en) Syringe and gasket therefor
GB2085006B (en) Insecticidal and acaricidal 2-arylethyl ether or thioether derivatives
DE3279352D1 (en) Optimization of an organization of many discrete elements
ZA81989B (en) Photoactive mixture of acrylic monomers and chromophoresubstituted halomethyl- -triazine
JPS5791921A (en) Medicine and manufacture
JPS57190034A (en) Modified ionomer and utilization
GB8317144D0 (en) Oxazolidine-2 4-diones
DK159864C (da) Dobbeltlaget hylster af et tekstilvaev og en acrylharpiksbelaegning til direkte omslutning af levnedsmidler og fremgangsmaade til fremstilling heraf.
AU575267B2 (en) Parkinsons disease treatments using threo-3-4hydroxyphenyl- serine and a decarboxylase inhibitor
AU6723181A (en) Treatment of pupae and a container
AU8923282A (en) 3-oxoestra-17-acetonitrile and unsaturated analogs
AU546219B2 (en) Acrylic copolymers
AU4779385A (en) Acrylic emulsion copolymers
OA08302A (fr) Dispositif pour l'application localisée d'un champ magnétique sur le corps humain.
AU4821679A (en) Insecticidal and acaricidal emulsion
GB8317147D0 (en) Oxazolidine-2 4-diones
GB2071091B (en) Acyl-derivatives of carnitine and the therapeutic use thereof
AU8629682A (en) Developer containing a pyrazolidone and hydroquinone
AU528525B2 (en) Insecticidal and acaricidal agents
JPS5756429A (en) Nose medicine and manufacture
GB2090099B (en) Digital tacan processor
JPS57182330A (en) Elastic film and manufacture
JPS57208590A (en) Character processor with function of correcting output pattern